Target Name: MIR1273A
NCBI ID: G100302165
Review Report on MIR1273A Target / Biomarker Content of Review Report on MIR1273A Target / Biomarker
MIR1273A
Other Name(s): MicroRNA 1273a | hsa-mir-1273a | MIRN1273 | hsa-mir-1273 | MIR1273

MIR1273A: A Potential Drug Target and Biomarker

MIR1273A is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. Its primary function is to regulate the levels of glucose in the body, which is crucial for maintaining proper energy metabolism. MIR1273A has been identified as a potential drug target and biomarker due to its unique structure and its involvement in glucose regulation.

The MIR1273A protein is a member of the MIR family, which includes several related proteins that are involved in the regulation of various physiological processes in the body. The MIR1273A protein is composed of 21 amino acid residues and has a calculated molecular mass of 21.1 kDa. It has a unique structure that consists of a single transmembrane domain and a cytoplasmic tail.

MIR1273A is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is highly expressed in the pancreas, which is responsible for producing insulin to regulate blood glucose levels. MIR1273A is also expressed in the brain, which is responsible for glucose metabolism and the regulation of appetite and energy expenditure.

MIR1273A's unique structure and its involvement in glucose regulation make it an attractive drug target. The transmembrane domain of MIR1273A is thought to play a crucial role in its glucose regulatory function. The domain is involved in the formation of a cation-exchange complex, which is responsible for the regulation of glucose uptake and release from the cell surface. The cytoplasmic tail of MIR1273A is also thought to be involved in its glucose regulatory function.

In addition to its potential drug target properties, MIR1273A has also been identified as a biomarker for various diseases. For example, MIR1273A has been used as a biomarker for non-alcoholic steatohepatitis (NASH), which is a type of liver disease that is characterized by the accumulation of fat in the liver. Studies have shown that MIR1273A is overexpressed in NASH patients and that inhibiting its activity may be a potential therapeutic approach for this disease.

MIR1273A has also been identified as a potential biomarker for other diseases, including cardiovascular disease and cancer. For example, MIR1273A has been shown to be overexpressed in patients with cardiovascular disease and that inhibiting its activity may be a potential therapeutic approach for this disease.

In conclusion, MIR1273A is a protein that is expressed in various tissues of the body and has been identified as a potential drug target and biomarker. Its unique structure and its involvement in glucose regulation make it an attractive target for drug development. Further research is needed to fully understand the role of MIR1273A in glucose regulation and its potential as a drug target and biomarker.

Protein Name: MicroRNA 1273a

The "MIR1273A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1273A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539